P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT ID: NCT07285096
Last Updated: 2025-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1730 participants
OBSERVATIONAL
2025-12-16
2026-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vonoprazan-based quadruple therapies
Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures
Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures.
tegoprazan-based quadruple therapies
Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures
Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures
Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing to receive H. pylori eradication therapy;
* diagnosed with H. pylori infection through at least one of the following methods: rapid urease test, ¹³C/¹⁴C-urea breath test, or histopathological examination.
Exclusion Criteria
* patients who received treatment regimens that did not comply with the quadruple regimens specified in this study.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qilu Hospital of Shandong University
OTHER
Feicheng People's Hospital
UNKNOWN
Binzhou Maternal and Child Health Hospital
UNKNOWN
Jinxiang County People's Hospital
UNKNOWN
The People's Hospital of Jimo
UNKNOWN
Zibo Maternal and Child Health Hospital
UNKNOWN
Yantai Penglai Traditional Chinese Medicine Hospital
UNKNOWN
Zaozhuang Municipal Hospital
OTHER
Linyi Yizhou Hospital
UNKNOWN
Taierzhuang District People's Hospital
OTHER
Shandong University of Traditional Chinese Medicine
OTHER
Yuncheng Traditional Chinese Medicine Hospital
OTHER
Caoxian County Hospital
UNKNOWN
Qihe County People's Hospital
UNKNOWN
University Town Hospital, Affiliated Hospital of Shandong University of Traditional Chinese Medicine
UNKNOWN
Dezhou Hospital Qilu Hospital of Shandong University
OTHER
The 2nd People's Hospital of Dongying City
UNKNOWN
Zhangdian District Hospital of Traditional Chinese Medicine
UNKNOWN
Yantai Zhifu Hospital
UNKNOWN
Inner Mongolia Autonomous Region International Mongolian Medicine Hospital
UNKNOWN
Hohhot Second Hospital
UNKNOWN
Guanxian People's Hospital
UNKNOWN
Longkou People's Hospital
UNKNOWN
Linshu County Hospital of Traditional Chinese Medicine
UNKNOWN
Yueyue Li
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yueyue Li
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu Hospital of Shandong University
Jinan, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yueyue Li
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202511
Identifier Type: -
Identifier Source: org_study_id